NovaBay Pharma (NBY) Tops Q3 EPS by 4c
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Financial Fact:
Income (loss) before income taxes: -3.74M
Today's EPS Names:
SYRS, EGRX, AIFC, More
Join SI Premium – FREE
NovaBay Pharma (NYSE: NBY) reported Q3 EPS of ($0.37), $0.04 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $3.27 million versus the consensus estimate of $3.54 million.
For earnings history and earnings-related data on NovaBay Pharma (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
- H.C. Wainwright Reiterates Buy Rating on Jasper Therapeutics (JSPR)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
